Pitney Bowes (PBI) Cash & Equivalents (2009 - 2026)

Pitney Bowes (PBI) has reported Cash & Equivalents for 18 consecutive years, with $266.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash & Equivalents fell 6.43% year-over-year to $266.8 million; the TTM figure through Jun 2026 stood at $266.8 million (down 6.43% YoY), while the FY2025 annual figure was $284.9 million, down 39.35% from the prior year.
• Cash & Equivalents slipped to $266.8 million in Q2 2026 per PBI's latest filing, from $302.9 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $668.3 million in Q4 2022 and bottomed at $266.8 million in Q2 2026.
• Historically, Cash & Equivalents has averaged $477.3 million across 5 years, with a median of $528.9 million in 2023.
• Annual changes were most pronounced in 2024 — Cash & Equivalents increased 8.94% — and 2025, when it tumbled 51.68%.
• Pitney Bowes' Cash & Equivalents stood at $668.3 million in 2022, then fell by 10.22% to $600.1 million in 2023, then decreased by 21.72% to $469.7 million in 2024, then plunged by 39.35% to $284.9 million in 2025, then decreased by 6.34% to $266.8 million in 2026.
• Business Quant data shows PBI's Cash & Equivalents at $266.8 million in Q2 2026, $302.9 million in Q1 2026, and $284.9 million in Q4 2025.